An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 38 (3), 431-438
- https://doi.org/10.1053/j.seminoncol.2011.03.014
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancerCritical Reviews in Oncology/Hematology, 2010
- Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI studyBreast Cancer Research and Treatment, 2010
- Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrainNeuroscience, 2010
- Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer SurvivorsJournal of Psychosocial Oncology, 2009
- Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memoryPsychopharmacology, 2008
- Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancerBrain, Behavior, and Immunity, 2008
- Alzheimer's Disease and Mild Cognitive ImpairmentNeurologic Clinics, 2007
- Cognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Research and Treatment, 2007
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007